These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22512565)

  • 21. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
    Muñoz M; Rosso M
    Invest New Drugs; 2010 Apr; 28(2):187-93. PubMed ID: 19148578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231.
    Bigioni M; Benzo A; Irrissuto C; Maggi CA; Goso C
    Anticancer Drugs; 2005 Nov; 16(10):1083-9. PubMed ID: 16222150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration.
    Dong J; Feng F; Xu G; Zhang H; Hong L; Yang J
    Gene; 2015 Apr; 560(2):205-10. PubMed ID: 25659767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of substance p/neurokinin-1 receptor in the analgesic and anticancer activities of minimally toxic fraction from the traditional Chinese medicine Liu-Shen-Wan in vitro.
    Li XJ; Jia MM; Li YS; Yang YL; Mao XQ; Tang HB
    Biol Pharm Bull; 2014; 37(3):431-8. PubMed ID: 24366059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
    Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
    Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
    Nizam E; Erin N
    Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NK-1 receptor is expressed in human primary gastric and colon adenocarcinomas and is involved in the antitumor action of L-733,060 and the mitogenic action of substance P on human gastrointestinal cancer cell lines.
    Rosso M; Robles-Frías MJ; Coveñas R; Salinas-Martín MV; Muñoz M
    Tumour Biol; 2008; 29(4):245-54. PubMed ID: 18781096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
    Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple Negative Breast Cancer: How Neurokinin-1 Receptor Antagonists Could Be Used as a New Therapeutic Approach.
    Muñoz M; Rosso M; Coveñas R
    Mini Rev Med Chem; 2020; 20(5):408-417. PubMed ID: 31721701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
    Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
    J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
    Robinson P; Coveñas R; Muñoz M
    Curr Med Chem; 2023; 30(16):1798-1812. PubMed ID: 35959620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the research and application of neurokinin-1 receptor antagonists.
    Hong X; Ma J; Zheng S; Zhao G; Fu C
    J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of substance P transport across the blood-brain barrier.
    Chappa AK; Audus KL; Lunte SM
    Pharm Res; 2006 Jun; 23(6):1201-8. PubMed ID: 16729222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NK-1 as a melanoma target.
    Muñoz M; Bernabeu-Wittel J; Coveñas R
    Expert Opin Ther Targets; 2011 Jul; 15(7):889-97. PubMed ID: 21592000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional neurokinin NK-1 receptor expression in rat peritoneal mast cells.
    Okada T; Hirayama Y; Kishi S; Miyayasu K; Hiroi J; Fujii T
    Inflamm Res; 1999 May; 48(5):274-9. PubMed ID: 10391116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
    Bert L; Rodier D; Bougault I; Allouard N; Le-Fur G; Soubrié P; Steinberg R
    Synapse; 2002 Jan; 43(1):62-9. PubMed ID: 11746734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
    Ge C; Huang H; Huang F; Yang T; Zhang T; Wu H; Zhou H; Chen Q; Shi Y; Sun Y; Liu L; Wang X; Pearson RB; Cao Y; Kang J; Fu C
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19635-19645. PubMed ID: 31488714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic activation of neurokinin-1 receptor induces pulmonary hypertension in rats.
    Chen LW; Chen CF; Lai YL
    Am J Physiol; 1999 May; 276(5):H1543-51. PubMed ID: 10330237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the interaction of diacylpiperazine antagonists with the human neurokinin-1 receptor: identification of a common binding site for structurally dissimilar antagonists.
    Cascieri MA; Shiao LL; Mills SG; MacCoss M; Swain CJ; Yu H; Ber E; Sadowski S; Wu MT; Strader CD
    Mol Pharmacol; 1995 Apr; 47(4):660-5. PubMed ID: 7536886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.